GlassScriptPhysician profile
Matthew Edward Powers
NPI 1033346812
$15,607.08
in general payments reported to CMS, 2019-2025
17 companies · $1,247 in 2025
The $1,247 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,073 · 2020: $504 · 2021: $898 · 2022: $1,176 · 2023: $926 · 2024: $6,783 · 2025: $1,247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,576 · Travel and Lodging: $3,060 · Consulting Fee: $2,250 · Education: $70.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,576.36 |
| Travel and Lodging | $3,059.73 |
| Consulting Fee | $2,250.00 |
| Education | $70.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $8,102.16 | 2019-2025 | Mitris Resilia Mitral Valve, Konect Resilia, Inspiris Resilia Aortic Valve |
| Atricure, INC. | $3,666.37 | 2019-2024 | |
| Abiomed | $1,458.83 | 2019-2025 | Impella |
| Abbott Laboratories | $1,203.04 | 2019-2025 | Aveir |
| Medtronic Vascular, INC. | $316.33 | 2019-2020 | |
| Medtronic, INC. | $232.79 | 2022-2024 | Penditure |
| Smith+Nephew, INC. | $173.80 | 2022-2025 | Pico |
| Davol INC. | $145.65 | 2024 | Arista Ah Flexitip |
| Zimmer Biomet Holdings, INC. | $70.59 | 2019-2020 | |
| Stryker Corporation | $45.45 | 2019 | |
| Ethicon US, LLC | $38.13 | 2019-2020 | |
| Depuy Synthes Sales INC. | $32.59 | 2021 | |
| Nuwellis, INC. | $30.85 | 2020 | |
| Kls-Martin L.P. | $26.90 | 2020 | |
| Solventum Corporation | $23.26 | 2024 | Prevena |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lemaitre Vascular, INC. | $21.59 | 2024 | Cardiocel |
| Grifols USA, LLC | $18.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Powers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.